Consensus Statements of the American College of Veterinary Internal Medicine (ACVIM) provide the veterinary community with up‐to‐date information on the pathophysiology, diagnosis, and treatment of clinically important animal diseases. The purpose of this report is to offer a consensus opinion of ACVIM oncology diplomates and technicians on the safe use of cytotoxic chemotherapeutics in veterinary practice. The focus is on minimizing harm to the personnel exposed to the drugs: veterinary practitioners, veterinary technicians, veterinary staff, and pet owners.
|
The safety of the patient receiving these drugs is also of paramount importance, but is not addressed in this statement.
Much of the information presented is based on national recommendations by Occupational Safety and Health Administration, National Institute for Occupational Safety and Health, United States Pharmacopeia, and other published regulations.
These directives reflect an abundance of caution to minimize exposure to medical personnel, but large‐scale studies about the consequences of long‐term occupational exposure are not available in veterinary medicine.
Challenges in the delivery of optimal treatment safely and economically to veterinary patients in general practice without access to a veterinary oncologist or other specialist, because of costs or proximity, remain.
The access is free!
Source: Annette N. Smith Shawna Klahn Brenda Phillips Lisa Parshley Peter Bennett Andi Flory Rosemary Calderon, ACVIM small animal consensus statement on safe use of cytotoxic chemotherapeutics in veterinary practice. JVIM Volume32, Issue3 May/June 2018,
Pages 904-913. First published: 30 March 2018 https://doi.org/10.1111/jvim.15077
|
